BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 33539852)

  • 1. Overcoming barriers by local drug delivery with liposomes.
    Antimisiaris SG; Marazioti A; Kannavou M; Natsaridis E; Gkartziou F; Kogkos G; Mourtas S
    Adv Drug Deliv Rev; 2021 Jul; 174():53-86. PubMed ID: 33539852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elastic liposomes as novel carriers: recent advances in drug delivery.
    Hussain A; Singh S; Sharma D; Webster TJ; Shafaat K; Faruk A
    Int J Nanomedicine; 2017; 12():5087-5108. PubMed ID: 28761343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical nanocarriers for management of Rheumatoid Arthritis: A review.
    Anita C; Munira M; Mural Q; Shaily L
    Biomed Pharmacother; 2021 Sep; 141():111880. PubMed ID: 34328101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaceutical aspects of intranasal delivery of vaccines using particulate systems.
    Sharma S; Mukkur TK; Benson HA; Chen Y
    J Pharm Sci; 2009 Mar; 98(3):812-43. PubMed ID: 18661544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal Nanoparticulate Systems as Alternative Route of Drug Delivery.
    Alshweiat A; Ambrus R; Csoka I
    Curr Med Chem; 2019; 26(35):6459-6492. PubMed ID: 31453778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in topical delivery of proteins and peptides mediated by soft matter nanocarriers.
    Witting M; Obst K; Friess W; Hedtrich S
    Biotechnol Adv; 2015 Nov; 33(6 Pt 3):1355-69. PubMed ID: 25687276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psoralen loaded liposomal nanocarriers for improved skin penetration and efficacy of topical PUVA in psoriasis.
    Doppalapudi S; Jain A; Chopra DK; Khan W
    Eur J Pharm Sci; 2017 Jan; 96():515-529. PubMed ID: 27777066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomal drug delivery systems: from concept to clinical applications.
    Allen TM; Cullis PR
    Adv Drug Deliv Rev; 2013 Jan; 65(1):36-48. PubMed ID: 23036225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Advances in Non-Invasive Delivery of Macromolecules using Nanoparticulate Carriers System.
    Shadab M; Haque S; Sheshala R; Meng LW; Meka VS; Ali J
    Curr Pharm Des; 2017; 23(3):440-453. PubMed ID: 27784250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges in development of targeted liposomal therapeutics.
    Sawant RR; Torchilin VP
    AAPS J; 2012 Jun; 14(2):303-15. PubMed ID: 22415612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Advancement in Topical Nanocarriers for the Treatment of Psoriasis.
    Biswasroy P; Pradhan D; Kar B; Ghosh G; Rath G
    AAPS PharmSciTech; 2021 May; 22(5):164. PubMed ID: 34041632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomal drug formulations in the treatment of rheumatoid arthritis.
    van den Hoven JM; Van Tomme SR; Metselaar JM; Nuijen B; Beijnen JH; Storm G
    Mol Pharm; 2011 Aug; 8(4):1002-15. PubMed ID: 21634436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposomes and micro/nanoparticles as colloidal carriers for nasal drug delivery.
    Mainardes RM; Urban MC; Cinto PO; Chaud MV; Evangelista RC; Gremião MP
    Curr Drug Deliv; 2006 Jul; 3(3):275-85. PubMed ID: 16848729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomes a vesicular nanocarrier: potential advancements in cancer chemotherapy.
    Kumar P; Gulbake A; Jain SK
    Crit Rev Ther Drug Carrier Syst; 2012; 29(5):355-419. PubMed ID: 22876808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential of nanoparticulate drug delivery systems by intranasal administration.
    Ali J; Ali M; Baboota S; Sahani JK; Ramassamy C; Dao L; Bhavna
    Curr Pharm Des; 2010 May; 16(14):1644-53. PubMed ID: 20210751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in topical nano drug-delivery systems for the anterior ocular segment.
    Lakhani P; Patil A; Majumdar S
    Ther Deliv; 2018 Feb; 9(2):137-153. PubMed ID: 29325511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligation strategies for targeting liposomal nanocarriers.
    Marqués-Gallego P; de Kroon AI
    Biomed Res Int; 2014; 2014():129458. PubMed ID: 25126543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Hypotonic Environmental Changes Affect Liposomal Formulations for Nose-to-Brain Targeted Drug Delivery.
    Wu IY; Nikolaisen TE; Škalko-Basnet N; di Cagno MP
    J Pharm Sci; 2019 Aug; 108(8):2570-2579. PubMed ID: 30885660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in topical ophthalmic drug delivery with lipid-based nanocarriers.
    Gan L; Wang J; Jiang M; Bartlett H; Ouyang D; Eperjesi F; Liu J; Gan Y
    Drug Discov Today; 2013 Mar; 18(5-6):290-7. PubMed ID: 23092895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-Steroidal Anti-Inflammatory Drugs Loaded Liposomes for Topical Treatment of Inflammatory and Degenerative Conditions.
    Matos C; Lobão P
    Curr Med Chem; 2020; 27(23):3809-3829. PubMed ID: 30827226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.